Sigilon Therapeutics, Inc. Stock
Equities
SGTX
US82657L2060
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 18-08-13 | |
Director of Finance/CFO | 58 | 19-10-31 | |
Philip Johnson
PSD | President | 59 | 23-08-10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 18-08-13 | |
Philip Johnson
PSD | President | 59 | 23-08-10 |
Gordon Brooks
BRD | Director/Board Member | - | 23-08-10 |
1st Jan change | Capi. | |
---|---|---|
+0.67% | 42.4B | |
+46.85% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
+16.03% | 11.32B | |
-4.80% | 11.55B |